Please enable JavaScript to continue using this application.

Compare $DMRA vs $VOR | Chartloom

Compare

$DMRA vs $VOR

Damora Therapeutics Inc · Vor Biopharma Inc

DMRA

Damora Therapeutics Inc

VOR

Vor Biopharma Inc

Compare $DMRA vs $VOR

Comparing Damora Therapeutics Inc and Vor Biopharma Inc

DMRADamora Therapeutics Inc

VORVor Biopharma Inc

DMRADamora Therapeutics Inc

Market cap

$1.30B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-17.4%

52W performance

-17.4%

FCF yield

-3.4%

VORVor Biopharma Inc

Market cap

$1.08B

P/E (TTM)

1.72x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

71.0%

52W performance

-40.4%

FCF yield

-13.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DMRA

VOR

Detailed metrics comparison

DMRA

Damora Therapeutics Inc

VOR

Vor Biopharma Inc

Market Cap

DMRA$1.30B

VOR$1.08B

Enterprise Value

DMRA$757M

VOR$971M

Price

DMRA$21.08

VOR$19.90

P/E Ratio

DMRAN/A

VOR1.72x

P/S Ratio

DMRA0.00x

VOR0.00x

EV/Sales

DMRA0.00x

VOR0.00x

EV/EBITDA

DMRA0.00x

VOR0.00x

P/B Ratio

DMRA2.47x

VOR16.48x

P/FCF Ratio

DMRAN/A

VORN/A

EV/FCF

DMRA-17.00x

VOR-6.89x

PEG Ratio

DMRAN/A

VORN/A

Forward P/E (NTM)

DMRAN/A

VORN/A

Forward P/S (NTM)

DMRAN/A

VORN/A

Revenue (TTM)

DMRA$0

VOR$0

Revenue Growth (YoY)

DMRAN/A

VORN/A

Forward Rev Growth

DMRA346.9%

VOR488.1%

Gross Margin (TTM)

DMRA0.0%

VOR0.0%

Operating Margin (TTM)

DMRA0.0%

VOR0.0%

EBITDA Margin (TTM)

DMRA0.0%

VOR0.0%

Net Margin (TTM)

DMRA0.0%

VOR0.0%

FCF Margin (TTM)

DMRAN/A

VORN/A

Net Income (TTM)

DMRA$-265M

VOR$628M

FCF (TTM)

DMRA$-45M

VOR$-141M

EPS (TTM)

DMRA-$4.34

VOR$11.56

ROE (TTM)

DMRA-8306.0%

VOR-14213.0%

ROA (TTM)

DMRA-7849.0%

VOR154.2%

ROIC (TTM)

DMRA-8306.0%

VOR-14213.0%

Cash

DMRA$541M

VOR$108M

Debt

DMRA$0

VOR$0

Net Cash/Debt

DMRA$541M

VOR$108M

Current Ratio (TTM)

DMRA19.73x

VOR19.15x

Quick Ratio (TTM)

DMRA19.70x

VOR18.91x

Debt/Equity (TTM)

DMRA0.00x

VOR0.00x

Debt/Assets (TTM)

DMRA0.0%

VOR0.0%

Interest Coverage (TTM)

DMRAN/A

VORN/A

Net Debt/EBITDA (TTM)

DMRA0.00x

VOR0.00x

Beta

DMRA-4.05

VOR1.70

52W Performance

DMRA-17.4%

VOR-40.4%

YTD Performance

DMRA-17.4%

VOR71.0%

% from 52W High

DMRA-39.6%

VOR-40.6%

% from 52W Low

DMRA27.8%

VOR206.2%

Asset Turnover (TTM)

DMRA0.00x

VOR0.00x

FCF Yield (TTM)

DMRA-3.4%

VOR-13.1%

Earnings Yield (TTM)

DMRA-20.4%

VOR58.2%

Dividend Yield (TTM)

DMRAN/A

VORN/A

Rule of 40

DMRA0.0

VOR0.0

EV/GP/RG

DMRAN/A

VORN/A

Ticker research

View DMRA research View VOR research

Metric	DMRA Damora Therapeutics Inc	VOR Vor Biopharma Inc
Market & Valuation
Market Cap	$1.30B	$1.08B
Enterprise Value	$757M	$971M
Price	$21.08	$19.90
P/E Ratio	N/A	1.72x
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.47x	16.48x
P/FCF Ratio	N/A	N/A
EV/FCF	-17.00x	-6.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	346.9%	488.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-265M	$628M
FCF (TTM)	$-45M	$-141M
EPS (TTM)	-$4.34	$11.56
ROE (TTM)	-8306.0%	-14213.0%
ROA (TTM)	-7849.0%	154.2%
ROIC (TTM)	-8306.0%	-14213.0%
Financial Health
Cash	$541M	$108M
Debt	$0	$0
Net Cash/Debt	$541M	$108M
Current Ratio (TTM)	19.73x	19.15x
Quick Ratio (TTM)	19.70x	18.91x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-4.05	1.70
52W Performance	-17.4%	-40.4%
YTD Performance	-17.4%	71.0%
% from 52W High	-39.6%	-40.6%
% from 52W Low	27.8%	206.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-3.4%	-13.1%
Earnings Yield (TTM)	-20.4%	58.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DMRA research	View VOR research

Valuation

P/E Ratio

VOR

1.72x

P/S Ratio

DMRA

0.00x

VOR

0.00x

EV/FCF

DMRA

-17.00x

VOR

-6.89x

Growth & revenue

Forward Revenue Growth

VOR

488.1%

DMRA

346.9%

Profitability & performance

Gross Margin

DMRA

0.0%

VOR

0.0%

ROE

DMRA

-8306.0%

VOR

-14213.0%

FCF Yield %

DMRA

-3.4%

VOR

-13.1%

52-Week Performance

DMRA

-17.4%

VOR

-40.4%

Detailed metrics comparison

DMRA

Damora Therapeutics Inc

VOR

Vor Biopharma Inc

Market Cap

DMRA$1.30B

VOR$1.08B

Enterprise Value

DMRA$757M

VOR$971M

Price

DMRA$21.08

VOR$19.90

P/E Ratio

DMRAN/A

VOR1.72x

P/S Ratio

DMRA0.00x

VOR0.00x

EV/Sales

DMRA0.00x

VOR0.00x

EV/EBITDA

DMRA0.00x

VOR0.00x

P/B Ratio

DMRA2.47x

VOR16.48x

P/FCF Ratio

DMRAN/A

VORN/A

EV/FCF

DMRA-17.00x

VOR-6.89x

PEG Ratio

DMRAN/A

VORN/A

Forward P/E (NTM)

DMRAN/A

VORN/A

Forward P/S (NTM)

DMRAN/A

VORN/A

Revenue (TTM)

DMRA$0

VOR$0

Revenue Growth (YoY)

DMRAN/A

VORN/A

Forward Rev Growth

DMRA346.9%

VOR488.1%

Gross Margin (TTM)

DMRA0.0%

VOR0.0%

Operating Margin (TTM)

DMRA0.0%

VOR0.0%

EBITDA Margin (TTM)

DMRA0.0%

VOR0.0%

Net Margin (TTM)

DMRA0.0%

VOR0.0%

FCF Margin (TTM)

DMRAN/A

VORN/A

Net Income (TTM)

DMRA$-265M

VOR$628M

FCF (TTM)

DMRA$-45M

VOR$-141M

EPS (TTM)

DMRA-$4.34

VOR$11.56

ROE (TTM)

DMRA-8306.0%

VOR-14213.0%

ROA (TTM)

DMRA-7849.0%

VOR154.2%

ROIC (TTM)

DMRA-8306.0%

VOR-14213.0%

Cash

DMRA$541M

VOR$108M

Debt

DMRA$0

VOR$0

Net Cash/Debt

DMRA$541M

VOR$108M

Current Ratio (TTM)

DMRA19.73x

VOR19.15x

Quick Ratio (TTM)

DMRA19.70x

VOR18.91x

Debt/Equity (TTM)

DMRA0.00x

VOR0.00x

Debt/Assets (TTM)

DMRA0.0%

VOR0.0%

Interest Coverage (TTM)

DMRAN/A

VORN/A

Net Debt/EBITDA (TTM)

DMRA0.00x

VOR0.00x

Beta

DMRA-4.05

VOR1.70

52W Performance

DMRA-17.4%

VOR-40.4%

YTD Performance

DMRA-17.4%

VOR71.0%

% from 52W High

DMRA-39.6%

VOR-40.6%

% from 52W Low

DMRA27.8%

VOR206.2%

Asset Turnover (TTM)

DMRA0.00x

VOR0.00x

FCF Yield (TTM)

DMRA-3.4%

VOR-13.1%

Earnings Yield (TTM)

DMRA-20.4%

VOR58.2%

Dividend Yield (TTM)

DMRAN/A

VORN/A

Rule of 40

DMRA0.0

VOR0.0

EV/GP/RG

DMRAN/A

VORN/A

Ticker research

View DMRA research View VOR research

Metric	DMRA Damora Therapeutics Inc	VOR Vor Biopharma Inc
Market & Valuation
Market Cap	$1.30B	$1.08B
Enterprise Value	$757M	$971M
Price	$21.08	$19.90
P/E Ratio	N/A	1.72x
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.47x	16.48x
P/FCF Ratio	N/A	N/A
EV/FCF	-17.00x	-6.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	346.9%	488.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-265M	$628M
FCF (TTM)	$-45M	$-141M
EPS (TTM)	-$4.34	$11.56
ROE (TTM)	-8306.0%	-14213.0%
ROA (TTM)	-7849.0%	154.2%
ROIC (TTM)	-8306.0%	-14213.0%
Financial Health
Cash	$541M	$108M
Debt	$0	$0
Net Cash/Debt	$541M	$108M
Current Ratio (TTM)	19.73x	19.15x
Quick Ratio (TTM)	19.70x	18.91x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-4.05	1.70
52W Performance	-17.4%	-40.4%
YTD Performance	-17.4%	71.0%
% from 52W High	-39.6%	-40.6%
% from 52W Low	27.8%	206.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-3.4%	-13.1%
Earnings Yield (TTM)	-20.4%	58.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DMRA research	View VOR research